COVID-19 related acute necrotizing encephalopathy presenting in the early postoperative period
Abstract
Keywords
Full Text:
PDFReferences
Kurushina OV, Barulin AE. Central Nervous System Lesions in COVID-19. Neurosci Behav Physiol. 2021;51(9):1222-1227. doi: 10.1007/s11055-021-01183-2. PMID: 35001988; PMCID: PMC8720549.
Divani AA, Andalib S, Biller J, et al. Central Nervous System Manifestations Associated with COVID-19. Curr Neurol Neurosci Rep. 2020;20(12):60. doi: 10.1007/s11910-020-01079-7. Erratum in: Curr Neurol Neurosci Rep. 2020;20(12):66. PMID: 33128130; PMCID: PMC7599061.
Nazari S, Azari Jafari A, Mirmoeeni S, et al. Central nervous system manifestations in COVID-19 patients: A systematic review and meta-analysis. Brain Behav. 2021;11(5):e02025. doi: 10.1002/brb3.2025. PMID: 33421351; PMCID: PMC7994971.
Giorgianni A, Vinacci G, Agosti E, et al. Transient acute-onset tetraparesis in a COVID-19 patient. Spinal Cord. 2020;58(9):1042-1044. doi: 10.1038/s41393-020-0493-8. Erratum in: Spinal Cord. 2020: PMID: 32488194; PMCID: PMC7264484.
Poyiadji N, Shahin G, Noujaim D, et al. COVID-19-associated Acute Hemorrhagic Necrotizing Encephalopathy: Imaging Features. Radiology. 2020;296(2):E119-E120. doi: 10.1148/radiol.2020201187. PMID: 32228363; PMCID: PMC7233386.
Jomaa N, El Halabi T, Melhem J, et al. COVID-19-Associated Acute Asymmetric Hemorrhagic Necrotizing Encephalopathy: A Case Report. Neurohospitalist. 2022;12(2):371-376. doi: 10.1177/19418744211055360. PMID: 35401914; PMCID: PMC8977755.
Garg RK, Paliwal VK, Malhotra HS, Sharma PK. Neuroimaging Patterns in Patients with COVID-19-Associated Neurological Complications: A Review. Neurol India. 2021;69(2):260-271. doi: 10.4103/0028-3886.314531. PMID: 33904434.
Bansal P, Fory EK, Malik S, Memon AB. Clinical Course of a Patient with Radiographically Described Acute Necrotizing Encephalopathy. Radiology. 2020;297(2):E278-E280. DOI: 10.1148/radiol.2020203132. PMID: 32787703; PMCID: PMC7427117.
Gadani S, Cohen A. Acute Necrotizing Encephalitis as an Early Manifestation of COVID-19. Cureus. 2022;14(8):e27928. doi: 10.7759/cureus.27928. PMID: 36120249; PMCID: PMC9464457.
Alqahtani A, Alaklabi A, Kristjansson S, et al. Acute necrotic hemorrhagic leukoencephalitis related to COVID-19: a report of 2 cases. Radiol Case Rep. 2021;16(9):2393-2398. doi: 10.1016/j.radcr.2021.05.072. PMID: 34104284; PMCID: PMC8173541.
Ray S, Kamath VV, Raju PA, Kn R, N S. Fulminant Reversible Cerebral Vasoconstriction Syndrome in Breakthrough COVID 19 Infection. J Stroke Cerebrovasc Dis. 2022;31(2):106238. doi: 10.1016/j.jstrokecerebrovasdis.2021.106238. PMID: 34915308; PMCID: PMC8616734.
Mousa H, Patel TH, Meadows I, Ozdemir B. Acute Disseminated Encephalomyelitis (ADEM) After Consecutive Exposures to Mycoplasma and COVID Vaccine: A Case Report. Cureus. 2022;14(6):e26258. doi: 10.7759/cureus.26258. PMID: 35911280; PMCID: PMC9312359.
Parsons T, Banks S, Bae C, et al. COVID-19-associated acute disseminated encephalomyelitis (ADEM). J Neurol. 2020;267(10):2799-2802. doi: 10.1007/s00415-020-09951-9. PMID: 32474657; PMCID: PMC7260459.
Miller TE, Garcia Beltran WF, Bard AZ, et al. Clinical sensitivity and interpretation of PCR and serological COVID-19 diagnostics for patients presenting to the hospital. FASEB J. 2020;34(10):13877-13884. doi: 10.1096/fj.202001700RR. PMID: 32856766; PMCID: PMC7461169.
Anka AU, Tahir MI, Abubakar SD, et al. Coronavirus disease 2019 (COVID-19): An overview of the immunopathology, serological diagnosis and management. Scand J Immunol. 2021;93(4):e12998. doi: 10.1111/sji.12998. PMID: 33190302; PMCID: PMC7744910.
Sterlin D, Mathian A, Miyara M, et al. IgA dominates the early neutralizing antibody response to SARS-CoV-2. Sci Transl Med. 2021;13(577):eabd2223. doi: 10.1126/scitranslmed.abd2223. PMID: 33288662; PMCID: PMC7857408.
Zervou FN, Louie P, Stachel A, et al. SARS-CoV-2 antibodies: IgA correlates with severity of disease in early COVID-19 infection. J Med Virol. 2021;93(9):5409-5415. doi: 10.1002/jmv.27058. PMID: 33932299; PMCID: PMC8242647.
Cervia C, Nilsson J, Zurbuchen Y, et al. Systemic and mucosal antibody responses specific to SARS-CoV-2 during mild versus severe COVID-19. J Allergy Clin Immunol. 2021;147(2):545-557.e9. doi: 10.1016/j.jaci.2020.10.040. PMID: 33221383; PMCID: PMC7677074.
Adjobimey T, Meyer J, Sollberg L, et al. Comparison of IgA, IgG, and Neutralizing Antibody Responses Following Immunization With Moderna, BioNTech, AstraZeneca, Sputnik-V, Johnson and Johnson, and Sinopharm's COVID-19 Vaccines. Front Immunol. 2022;13:917905. doi: 10.3389/fimmu.2022.917905. PMID: 35799790; PMCID: PMC9254618.
Al-Tamimi M, Tarifi AA, Qaqish A, et al. Immunoglobulins response of COVID-19 patients, COVID-19 vaccine recipients, and random individuals. PLoS One. 2023;18(2):e0281689. doi: 10.1371/journal.pone.0281689. PMID: 36787317; PMCID: PMC9928079.
DOI: http://dx.doi.org/10.22551/2023.39.1002.10246
Copyright (c) 2023 Elissavet Symeonidou, Androniki Dimitriadou, Antonios Morsi-Yeroyannis, Maria S Sidiropoulou, Ioannis Gkoutziotis, Panagiotis Petras, Konstantinos Mpallas
Archive of Clinical Cases is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
ISSN: 2360-6975